Heyholder
‹ Activism FilingsMajor

P&K Skin Research Center Co.,Ltd. Q3 profit from the main business KRW 1.2 billion, up 167.3% from a year earlier

P&K Skin Research Center Co.,Ltd.· Periodic Report

AI summary · Not investment advice

In Q3, the company sold KRW 6.8 billion of goods and earned KRW 1.2 billion from its main business, up 167.3% from a year earlier and down 20.0% from the prior quarter.

Operating profit · 3 months

KRW 1.2 billion

Key facts

Revenue (3 months)
KRW 6.8 billion
Net income (3 months)
KRW 556.5 million
Period
Q3 (cumulative 2026.01.01 ~ 2026.09.30)
Revenue (prior-year 3 months)
KRW 5.1 billion
Revenue (year to date)
KRW 19.6 billion
Operating profit (prior-year 3 months)
KRW 451.8 million
Operating profit (year to date)
KRW 3.7 billion
Net income (prior-year 3 months)
KRW 1.6 billion
Net income (year to date)
KRW 3.5 billion

Commentary

AI commentary · Not investment advice

What happened

PNK Skin Clinical Research Center reported its consolidated results for the third quarter of 2026 in a quarterly report.

In the company's terms

Sales for the latest 3 months were KRW 6.76 billion. That is up 33.8% from the same 3 months a year earlier and up 2.5% from the previous quarter. Cumulative sales this year are KRW 19.59 billion.

What changes for shareholders

Operating profit (profit from the core business) for the latest 3 months was KRW 1.21 billion. That is up 167.3% from a year earlier and down 20.0% from the previous quarter. Cumulative operating profit this year is KRW 3.68 billion.

Net income (the final profit after taxes and other costs) for the latest 3 months was KRW 556.5 million. That is down 64.6% from a year earlier and down 63.1% from the previous quarter. Cumulative net income this year is KRW 3.52 billion.

Comments

No comments yet

Comments from shareholders will appear here.